Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
ACTIVE NOT RECRUITINGN/A

Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study

Sponsor: Cardiovascular and Interventional Radiological Society of Europe

NCT ID: NCT06149650

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Health checks and monitoring — no treatment given
Type of study
Observational (no treatment given)
Time in hospital
In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention
Shockwave Medical IVL System (device)
How long the study runs
Study runs about 53 months (dates as stated)
About the drug or intervention
Shockwave Medical IVL System — device: Comprehensive system consisting of generator, a connector cable and a single-use sterile catheter with integrated balloon for intravascular lithotripsy of peripheral artery calcification.
Patient visit burden
Not specified by the sponsor
Type of study
Observing health over time
Ages
18 Years and over
Who
All
Number of participants
400
Started
2024-07-15
Last checked
2026-07

Plain English Summary

What is this study?

  • • Testing a new treatment for chronic limb-threatening ischemia
  • • Clinical study - 400 participants
  • • CALCIO is a multicentre, prospective, observational cohort study that will collect real world data on the use of intravascular Lithotripsy (IVL) with the Shockwave IVL system to disrupt calcified femoropopliteal and crural lesions in patients with chronic limb-threatening ischemia (CLTI)

Who can take part?

  • • Ages 18 Years and over
  • • Diagnosed with chronic limb-threatening ischemia

Where?

  • • Bedford - Bedfordshire Hospitals NHS Foundation Trust
  • • Frimley - Frimley Health NHS Foundation Trust
  • • Hull - Hull University Teaching Hospitals NHS Trust
  • • Leeds - Leeds Teaching Hospitals NHS Trust
  • • +10 more UK sites

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

CALCIO is a multicentre, prospective, observational cohort study that will collect real world data on the use of intravascular Lithotripsy (IVL) with the Shockwave IVL system to disrupt calcified femoropopliteal and crural lesions in patients with chronic limb-threatening ischemia (CLTI). The primary objective of CALCIO is to understand the effectiveness of IVL in promoting wound healing and preventing amputation. The secondary objectives of CALCIO are to evaluate the immediate effectiveness of the treatment in restoring vessel patency as well as its safety and impact on patients' quality of life.

Chronic Limb-Threatening Ischemia

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: 18 Years and over
  • Who can join: All genders

What the study is looking for

  • ✓Patient with chronic limb-threatening ischemia (Rutherford Category ≥4)
  • ✓Femoropopliteal and/or crural calcified lesions visible on fluoroscopy;
  • ✓Treatment with IVl using the Shockwave Medical IVL System.

Who cannot take part

  • ✗\< 18 years old;
  • ✗Incapacity or refusal to give agreement to take part;
  • ✗Ongoing pregnancy;
  • ✗Endovascular procedure(s) on the treatment site within 4 weeks before the planned IVL treatment.
See the full criteria
Inclusion Criteria: * Patient with chronic limb-threatening ischemia (Rutherford Category ≥4) * Femoropopliteal and/or crural calcified lesions visible on fluoroscopy; * Treatment with IVl using the Shockwave Medical IVL System. Exclusion Criteria: * \< 18 years old; * Incapacity or refusal to give informed consent; * Ongoing pregnancy; * Endovascular procedure(s) on the treatment site within 4 weeks before the planned IVL treatment.

Where Is This Study? (14 UK sites)

Bedfordshire Hospitals NHS Foundation Trust

Bedford MK42 9DJ, United Kingdom

Hospital R&D contact (matched)

Dr. Mohammad Wasil. Assistant Director of RD&I

research.bedford@bedsft.nhs.ukContact:

Frimley Health NHS Foundation Trust

Frimley GU16 7UJ, United Kingdom

Hospital R&D contact (matched)

Clare Denford

fhft.research-innovation@nhs.net0300 613 2301

Hull University Teaching Hospitals NHS Trust

Hull HU3 2JZ, United Kingdom

Hospital R&D contact (matched)

James Illingworth

hyp-tr.development.research@nhs.net01482 461883 or 461903

Leeds Teaching Hospitals NHS Trust

Leeds LS1 3EX, United Kingdom

Hospital R&D contact (matched)

R&I Team

leedsth-tr.researchfacilitation@nhs.net0113 2060469

Liverpool University Hospitals NHS Foundation Trust

Liverpool L7 8XP, United Kingdom

Hospital R&D contact (matched)

Louise Hardman

louise.hardman@lwh.nhs.uk0151 702 4241

University College London Hospitals NHS Foundation Trust

London NW1 2PG, United Kingdom

Hospital R&D contact (matched)

Rajinder Sidhu - Associate Director, Research Governance and Operations

uclh.jro-communications@nhs.net020 3447 9825

Royal Free London NHS Foundation Trust

London NW3 2QG, United Kingdom

Hospital R&D contact (matched)

Natasha Ajraam

rf-tr.randd@nhs.net020 375 82150

St George's University Hospitals NHS Foundation Trust

London SW17 0QT, United Kingdom

Hospital R&D contact (matched)

Mr Subhir Bedi

researchgovernance@sgul.ac.uk020 8725 4986

Imperial College Healthcare NHS Trust

London W2 1NY, United Kingdom

Hospital R&D contact (matched)

Donna Copeland

donna.copeland@nhs.net---

Manchester University NHS Foundation Trust

Manchester M13 9WL, United Kingdom

Hospital R&D contact (matched)

Elizabeth Mainwaring

R&D.applications@mft.nhs.uk0161 276 3340

Newcastle upon Tyne Hospitals NHS Foundation Trust

Newcastle NE1 4LP, United Kingdom

Hospital R&D contact (matched)

Research and Development

nuth.genericqueries@nhs.net0191 282 4926

Oxford University Hospitals NHS Foundation Trust

Oxford OX3 9DU, United Kingdom

Hospital R&D contact (matched)

Shahista Hussain

ouhtma@ouh.nhs.uk---

University Hospitals Plymouth NHS Trust

Plymouth PL6 8DH, United Kingdom

Hospital R&D contact (matched)

R&D Manager

plh-tr.RD-office@nhs.net01752 431776

Sheffield Teaching Hospitals NHS FT

Sheffield S10 2JF, United Kingdom

Hospital R&D contact (matched)

Alessia Dunn

STH.ResearchAdministration@nhs.net0114 2712550
Data sourced from ClinicalTrials.gov · Last verified: 2026-07